DI
Nascent Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pritumumab (PTB) | Gliomas (Brain Tumors) | Phase II |
| Pritumumab-based ADC | Undisclosed Cancers | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| Pritumumab (PTB) | Gliomas (Brain Tumors) | Phase II |
| Pritumumab-based ADC | Undisclosed Cancers | Discovery |